menu
    • menu

    Company profile for Avata Biosciences

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avata Biosciences, previously known as Sapient Therapeutics Ltd., stands as a clinical-stage biopharmaceutical enterprise committed to enhancing the quality of life for individuals grappling with neurological disorders. Our focus lies in the development of synthetic cannabinoids and a pioneering formulation process aimed at catering to broader patient demographics. We are dedicated to pioneering next-generation medicines tailo...
    Avata Biosciences, previously known as Sapient Therapeutics Ltd., stands as a clinical-stage biopharmaceutical enterprise committed to enhancing the quality of life for individuals grappling with neurological disorders. Our focus lies in the development of synthetic cannabinoids and a pioneering formulation process aimed at catering to broader patient demographics. We are dedicated to pioneering next-generation medicines tailored for patients afflicted with epilepsy and various other neurological diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avata BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    254 Park Av. South New York, NY 10010
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avatabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avata Biosciences Signs Co-Development Agreement with Oceanus Bio
    Avata Biosciences Signs Co-Development Agreement with Oceanus Bio

    17 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250617132917/en/Avata-Biosciences-Signs-Co-Development-and-Licensing-Agreement-with-Oceanus-Bio-for-Exclusive-Rights-in-Japan-and-Asia-Excluding-China-and-India-for-Novel-Adult-and-Pediatric-Oral-Cannabidiol-Therapies-for-Development-in-Epilepsy-and-Schizophrenia

    BUSINESSWIRE
    17 Jun 2025
    Share Share
    Avata Biosciences Emerges With Cannabinoid Epilepsy Programs
    Avata Biosciences Emerges With Cannabinoid Epilepsy Programs

    13 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240513306281/en

    BUSINESSWIRE
    13 May 2024
    Share Share
    Sapient Appoints Jonathan Usuka as Chief Business Officer
    Sapient Appoints Jonathan Usuka as Chief Business Officer

    07 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240507157079/en

    BUSINESSWIRE
    07 May 2024
    Share Share
    Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics
    Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics

    06 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240129288657/en

    BUSINESSWIRE
    06 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search